AFAdam Frankel

Adam Frankel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Adam Frankel has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cost–Utility Analysis of Wireless Versus Catheter‐Based Oesophageal pH Monitoring in the Pre‐Operative Assessment of Anti‐Reflux Surgery: A Decision‐Analytic Model

    by Du H. Phan, Naomi Moy, Iain G. Thomson, Adam J. Frankel

    Background: Distal oesophageal pH testing is an important component of the pre‐operative workup for anti‐reflux surgery, providing diagnostic confirmation and prognostic information. Catheter‐based reflux testing is currently the standard modality in Australia. Although associated with improved patient tolerability, wireless testing remains limited by access and funding restrictions. Methods: A cost–utility analysis was conducted to compare the cost‐effectiveness of wireless versus catheter‐based reflux monitoring before anti‐reflux surgery. Health service costs (administrative, labour, and equipment) and EuroQol 5‐Dimension‐derived utility weights were used to calculate incremental costs per quality‐adjusted life‐year (QALY) over a one‐year time horizon. Results: Wireless pH monitoring was associated with marginally lower costs and higher QALYs compared with catheter‐based monitoring (AUD $11001.51 vs. AUD $11210.47; 0.87 vs. 0.82 QALYs). The base‐case incremental cost‐effectiveness ratio was −AUD $5026.64 per QALY, indicating that wireless monitoring was the dominant strategy. At a willingness‐to‐pay threshold of AUD $50 000 per QALY, the incremental net monetary benefit was AUD $2287.47, indicating potential cost‐effectiveness. One‐way sensitivity analyses suggested that base‐case findings were robust across key parameter variations. Conclusion: Within this model evaluating the pH testing component of the pre‐operative work‐up, wireless monitoring may represent a cost‐effective alternative to catheter‐based monitoring without substantially increasing healthcare costs.

  • Beyond symptom improvement: a qualitative study of patient-defined treatment goals and surgical success after anti-reflux surgery

    by Du Huynh Phan, Nicole Marinucci, Iain Gregory Thomson, Adam John Frankel

    Summary: Gastro-esophageal reflux disease (GORD) has multifactorial effects that substantially impair quality of life. Anti-reflux surgery (ARS) is an established treatment for appropriately selected patients; however, current outcome reporting is largely symptom-focused and may not fully capture patient-derived goals and expectations that shape perceptions of surgical success. A qualitative study using semi-structured interviews and inductive thematic analysis was conducted in postoperative patients at a tertiary upper gastrointestinal surgical unit in Australia. Patient-identified experiences of GORD, expectations of surgery, and perceived determinants of surgical success were explored. Participants described GORD as a chronic condition with pervasive impacts on daily functioning and psychosocial wellbeing. Surgery was primarily motivated by the desire to restore everyday functioning, reduce medication reliance, and exclude serious pathology. Surgical success was evaluated according to multidimensional, patient-defined goals centered on functional improvement. Satisfaction depended on concordance between post-operative outcomes and preoperative expectations. Rather than pursuing complete symptom resolution, some patients may accept trade-offs to prioritize individual treatment goals. Dissatisfaction was commonly associated with new non-reflux symptoms, particularly when these caused unexpected functional limitations, despite effective reflux control. Patients evaluated satisfaction according to the extent to which postoperative outcomes aligned with patient-specific, function-focused treatment goals. A patient-centered approach to ARS should therefore include exploration of patients’ motivations for surgery and goals to guide expectation setting and shared decision-making. Incorporating functional outcomes alongside conventional symptom measures may further improve the evaluation of surgical success.

  • Open Access

    A Cost Analysis of All‐Staff Emails in an Australian Hospital Network ( CASH Study)

    by Arthur Samoylovich, Adam J. Frankel

    Background: Written communication has changed dramatically in the computer era. Email use has exploded in the last three decades, from the inter‐individual level through to mass dissemination. In the workplace, it has become the default mode of communication despite very limited critical appraisal. Specifically in the healthcare setting, its utility as a communication strategy for broadcasting information has barely been examined. The aim of this study was to quantify the use of all‐staff emails (ASE) across a public hospital and its umbrella Hospital and Health Service (HHS). Method: An audit of one year's ASE was performed to determine the number, word count and readability using validated metrics. The median was used as a reference text. Seventy five randomly selected volunteers from the five occupation groups in the health service were timed whilst reading the reference text to enable an estimate of time and financial cost. Results: Five hundred and six ASE were identified, with a median length of 622 words (95% CI 570 to 694). The median Flesch–Kincaid (FK) Grade score was 8.9 (95% CI 8.8 to 9.1). The calculated predicted salary costs if all staff read all ASE in 1 year were AU$6 116 386.47 (range AU$3 441 365.32 to AU$13 424 704.98) at the hospital level and AU$14 555 209.62 (range AU$8 258 984.03 to AU$31 778 109.75) at the HHS level. Conclusions: A modest reduction in annual ASE burden could result in considerable savings for hospitals and hospital health services, which could be reinvested into patient care, procedures and staff wellbeing. Further research would improve the limited understanding of the impacts of ASE and build an evidence base for how to optimise their use.

  • Textbook outcomes for oesophagectomy: A valid composite measure assessment tool for surgical performance in a specialist unit

    by Michael Yulong Wu, Richard J. McGregor, Justin Scott, B Mark Smithers, Janine Thomas, Adam Frankel, Andrew Barbour, Iain Thomson


  • Laparoscopic fundoplication after lung transplantation does not appear to alter lung function trajectory

    by Adam Frankel, Trina Kellar, Farah Zahir, Daniel Chambers, Peter Hopkins, David Gotley


  • Open Access

    Laparoscopic fundoplication versus laparoscopic Roux-en-Y gastric bypass for gastro-oesophageal reflux disease in obese patients: protocol for a randomized clinical trial

    by Adam Frankel, Iain Thomson, Ayesha Shah, Chen Chen, Syeda Farah Zahir, Andrew Barbour, Gerald Holtmann, B Mark Smithers

    Laparoscopic fundoplication (LF) is the standard surgical procedure for the treatment of gastro-oesophageal reflux disease (GORD). Laparoscopic Roux-en-Y gastric bypass (LRYGB) is commonly performed to achieve weight loss in obese patients, but it also has anti-reflux properties. Hence, in the obese population suffering from GORD, LRYGB could be an alternative to LF. The aim of this trial will be to compare LF and LRYGB in an obese population presenting with GORD and being considered for surgery. This will be an investigator-initiated randomized clinical trial. The research population will be obese patients (BMI 30–34.9 with waist circumference more than 88 cm (women) or more than 102 cm (men), or BMI 35–40 with any waist circumference) referred to a public hospital for consideration of anti-reflux surgery. The primary aim of the study will be to determine the efficacy of LF compared with LRYGB on subjective and objective control of GORD. Secondary aims include determining early and late surgical morbidity and the side-effect profile of LF compared with LRYGB and to quantify any non-reflux benefits of LRYGB (including overall quality of life) compared with LF. This trial will determine whether LRYGB is effective and acceptable as an alternative to LF for the surgical treatment of GORD in obese patients Registration number: Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12622000636752p (https://www.anzctr.org.au/).


  • Open Access

    Efficacy of laparoscopic fundoplication in patients with chronic cough and gastro-oesophageal reflux

    by Adam Frankel, Hock Soo Ong, B. Mark Smithers, Les K. Nathanson, David C. Gotley

    Background: The outcome of anti-reflux surgery in patients with suspected gastro-oesophageal reflux-induced cough is frequently uncertain. The aims of this study were to assess the efficacy of laparoscopic fundoplication for controlling cough in patients with chronic cough without asthma, who have pathologic gastro-oesophageal reflux, and to identify predictors of response.Methods: From a prospective database of 1598 patients who have undergone laparoscopic fundoplication, 66 (4%) with proven gastro-oesophageal reflux disease (GORD) and chronic cough without asthma were studied. All patients underwent gastroscopy and 24-h pH monitoring before operation. Heartburn and regurgitation were assessed using a modified DeMeester score. Severity of cough before and after surgery was self-assessed by the patient using a visual analog scale at a minimum of 12 months post-operatively (median 43 mo; range: 14–104 mo). Patients were considered to have responded to fundoplication if they had no cough or the cough had improved by 50% or more after operation.Results: Cough and heartburn/regurgitation were relieved in 61% (40/66) and 90% (44/49) of the patients, respectively. The presence of typical GORD symptoms or oesophagitis, and pH study variables did not predict the response of the cough to fundoplication.Conclusion: Refinement in the aetiological diagnosis of chronic cough due to GORD is necessary for improved outcome. Patients diagnosed with GORD-related chronic cough need to be counseled regarding their expectations from anti-reflux surgery.


  • Open Access

    Esophageal perforations – a population-based nationwide study in Sweden with survival analysis

    by David Edholm, Roland E. Andersson, Adam Frankel

    Esophageal perforation is a rare and life-threatening condition with several treatment options. The aim was to assess the incidence, type of treatment and mortality of esophageal perforations in Sw...


  • Subcutaneous neostigmine appears safe and effective for acute colonic pseudo‐obstruction (Ogilvie's syndrome)

    by Adam Frankel, Christopher Gillespie, Cu‐Tai Lu, Peter Hewett, David Wattchow

    Background: Intravenous neostigmine is a well‐established treatment for acute colonic pseudo‐obstruction (ACPO). Its use is hampered by the perceived requirement for continuous cardiac monitoring, and patients are often transferred to high‐dependency units for close observation during treatment. Subcutaneous neostigmine has the potential to minimize adverse cardiovascular effects while maintaining efficacy. This study aims to assess the safety of subcutaneous neostigmine on ward inpatients with ACPO monitored with standard nursing care.Methods: This is a retrospective case series of 30 patients with ACPO who were treated with subcutaneous neostigmine between August 2008 and October 2012. Data were collected prospectively. All patients were diagnosed using clinical examination and radiology and were assessed for contraindications to neostigmine. Patients were treated on regular wards and monitored with standard nursing observations. The main outcomes were time to flatus and bowels working and complications.Results: No serious complications such as clinically evident bradycardia were encountered. Ninety‐three percent of patients had clinically successful resolution of ACPO. Two patients (7%) developed caecal tenderness and proceeded to colonoscopic decompression, which was successful in both instances.Conclusions: Subcutaneous neostigmine appears to be safe for the treatment of ACPO. No clinically evident serious adverse events occurred, meaning continuous cardiac monitoring as a routine may not be necessary. In our cohort, we achieved similar success rates compared with reported rates using intravenous neostigmine.